Associations among Race/Ethnicity, ApoC-III Genotypes, and Lipids in HIV-1-Infected Individuals on Antiretroviral Therapy.

Associations among Race/Ethnicity, ApoC-III Genotypes, and Lipids in HIV-1-Infected Individuals on Antiretroviral Therapy.

BACKGROUND: Protease inhibitors (PIs) are associated with hypertriglyceridemia and atherogenic dyslipidemia. Identifying HIV-1-infected individuals who are at increased risk of PI-related dyslipidemia will facilitate therapeutic choices that maintain viral suppression while reducing risk of atherosc...

Full description

Bibliographic Details
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2006-01-01
Series:	PLoS Medicine
Online Access:	http://dx.doi.org/10.1371/journal.pmed.0030052

Similar Items

Triglyceride-rich lipoprotein metabolism in women: roles of apoC-II and apoC-III
by: Hodson, L, et al.
Published: (2016)

Quantification of apoC-II and apoC-III of human very low density lipoproteins by analytical isoelectric focusing.
by: A L Catapano, et al.
Published: (1978-11-01)

Identification of an apoC-II variant (apoC-IIBethesda) in a kindred with apoC-II deficiency and type I hyperlipoproteinemia.
by: D L Sprecher, et al.
Published: (1988-03-01)

Effect of apoC-III gene polymorphisms on the lipoprotein-lipid profile of viscerally obese men
by: Charles Couillard, et al.
Published: (2003-05-01)

Ethnic differences in ApoC-III concentration and the risk of cardiovascular disease: No evidence for the cardioprotective role of rare/loss of function APOC3 variants in non-Europeans
by: Madhusmita Rout, et al.
Published: (2022-01-01)

The Roles of ApoC-III on the Metabolism of Triglyceride-Rich Lipoproteins in Humans
by: Jan Borén, et al.
Published: (2020-07-01)

Sex differences in HDL ApoC-III in American Indian youth
by: Blackett Piers R, et al.
Published: (2012-08-01)

ApoC-III gene polymorphisms and risk of coronary artery disease
by: Oliviero Olivieri, et al.
Published: (2002-09-01)

AAV-Mediated ApoC2 Gene Therapy: Reversal of Severe Hypertriglyceridemia and Rescue of Neonatal Death in ApoC2-Deficient Hamsters
by: Chun Yang, et al.
Published: (2020-09-01)

Monoclonal antibody to rat apoC: multiple binding to apoC-I on lipoproteins increases its affinity constant.
by: L Wong
Published: (1985-07-01)

ApoC-III content of apoB-containing lipoproteins is associated with binding to the vascular proteoglycan biglycan
by: Katherine Olin-Lewis, et al.
Published: (2002-11-01)

Storage of human plasma samples leads to alterations in the lipoprotein distribution of apoC-III and apoE
by: Jeffrey S. Cohn, et al.
Published: (2004-08-01)

Association of plasma lipids and apolipoproteins with the insulin response element in the apoC-III promoter region in familial combined hyperlipidemia
by: M. Groenendijk, et al.
Published: (1999-06-01)

Race/Ethnicity, Lipoproteins, and Antiretroviral Therapy.
Published: (2006-03-01)

ApoC-IIParis2: a premature termination mutation in the signal peptide of apoC-II resulting in the familial chylomicronemia syndrome.
by: CL Parrott, et al.
Published: (1992-03-01)

Evidence for a complex relationship between apoA-V and apoC-III in patients with severe hypertriglyceridemia
by: Frank G. Schaap, et al.
Published: (2006-10-01)

ApoC-III ASO promotes tissue LPL activity in the absence of apoE-mediated TRL clearance
by: Bastian Ramms, et al.
Published: (2019-08-01)

ApoE2-associated hypertriglyceridemia is ameliorated by increased levels of apoA-V but unaffected by apoC-III deficiency*
by: Gery Gerritsen, et al.
Published: (2008-05-01)

Isolation and characterization of cDNA clones corresponding to two different human apoC-III alleles.
by: S K Karathanasis, et al.
Published: (1985-04-01)

Interventional hepatic apoC-III knockdown improves atherosclerotic plaque stability and remodeling by triglyceride lowering
by: Bastian Ramms, et al.
Published: (2022-07-01)

Identification of Rev-erbα as a physiological repressor of apoC-III gene transcription1
by: Eric Raspé, et al.
Published: (2002-12-01)

Biological and genetic determinants of serum apoC-III concentration: reference limits from the Stanislas Cohort
by: Peggy Tilly, et al.
Published: (2003-02-01)

LPL gene variants affect apoC-III response to combination therapy of statins and fenofibric acid in a randomized clinical trial of individuals with mixed dyslipidemia
by: Ariel Brautbar, et al.
Published: (2012-03-01)

Reduction in lipoprotein-associated apoC-III levels following volanesorsen therapy: phase 2 randomized trial results1
by: Xiaohong Yang, et al.
Published: (2016-04-01)

Isolation and characterization of polymorphic forms of porcine apoC-II by chromatofocusing.
by: G Knipping, et al.
Published: (1984-01-01)

Metabolsim of apoB and apoC lipoproteins in man: kinetic studies in normal and hyperlipoproteininemic subjects
by: M Berman, Ph.D., et al.
Published: (1978-01-01)

Associations of HDL Subspecies Defined by ApoC3 with Non-Alcoholic Fatty Liver Disease: The Multi-Ethnic Study of Atherosclerosis
by: Jakub Morze, et al.
Published: (2020-10-01)

Further characterization of the metabolic properties of triglyceride-rich lipoproteins from human and mouse apoC-III transgenic mice.
by: K Aalto-Setälä, et al.
Published: (1996-01-01)

ApoC3 is expressed in oocytes and increased expression is associated with PCOS progression
by: Jiahe Zhou, et al.
Published: (2023-09-01)

Plasma kinetics of VLDL and HDL apoC-I in normolipidemic and hypertriglyceridemic subjects
by: Jeffrey S. Cohn, et al.
Published: (2002-10-01)

A novel apolipoprotein C-III variant, apoC-III(Gln38–>Lys), associated with moderate hypertriglyceridemia in a large kindred of Mexican origin
by: C R Pullinger, et al.
Published: (1997-09-01)

Using primary murine intestinal enteroids to study dietary TAG absorption, lipoprotein synthesis, and the role of apoC-III in the intestine[S]
by: Javeed Jattan, et al.
Published: (2017-05-01)

Molecular cloning of a human apoC-III variant: Thr 74----Ala 74 mutation prevents O-glycosylation.
by: H Maeda, et al.
Published: (1987-12-01)

Targeting ApoC3 Paradoxically Aggravates Atherosclerosis in Hamsters With Severe Refractory Hypercholesterolemia
by: Yitong Xu, et al.
Published: (2022-02-01)

Effects of apoC1 genotypes on the hormonal levels, metabolic profile and PAF-AH activity in Chinese women with polycystic ovary syndrome
by: Renjiao Zhang, et al.
Published: (2018-04-01)

Hypercholesterolemia is associated with the apolipoprotein C-III (APOC3) genotype in children receiving HAART: an eight-year retrospective study.
by: Carlos A Rocco, et al.
Published: (2012-01-01)

Correlation between Serum ApoC III and Galectin-3 Levels and Maternal and Neonatal Adverse Outcomes in Gestational Diabetes Mellitus Patients
by: Tingting Tang, et al.
Published: (2022-01-01)

Expression of a novel human apolipoprotein (apoC-IV) causes hypertriglyceridemia in transgenic mice.
by: C M Allan, et al.
Published: (1996-01-01)

Retracted: Correlation between Serum ApoC III and Galectin-3 Levels and Maternal and Neonatal Adverse Outcomes in Gestational Diabetes Mellitus Patients
by: Emergency Medicine International
Published: (2024-01-01)

Aromatic residues in the C-terminal helix of human apoC-I mediate phospholipid interactions and particle morphology[S]
by: Patrick F. James, et al.
Published: (2009-07-01)